Week 4 - Chronic Heart Failure Treatments Flashcards

1
Q

What is the aim of treatment?

A
  • improve status and functional capacity of patient,
  • QoL,
  • prevent hospital admission
  • reduce mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the neuro-hormonal antagonists we use?

A

ACE inhibitors, ARB’s, ARNI
b blockers
MRA - mineralcorticoid receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a loop diuretic example and its role?

A

furosemide. inhibits ion transporters at loop of henle to reduce salt and water retention. works at low GFR’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are issues with loop diuretics?

A
  • patient may become resistant by other transport mechanisms being activated
  • oedema in gut may prevent drug absorption
  • oedema may continue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you overcome loop diuretic resistance? Whats an issue?

A

furosemide with thiazides.

pee a lot. risk dehydration, hypotension, hyponatraemia, hypokalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What ACE inhibitors are used?

A

ramipril, enalapril, lisinopril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the benefit and negatives of ACE inhibitors in HF patients?

A
  • used first line. reduces mortality
  • many ADR’s and drug-drug interractions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is ARB’s and when is it used?

A

candesartan. angiotensin II receptor blockers. in ACE resistance or cough as a side effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is an ARNI?

A

Valsartan-sacubitral
angiotensin II receptor blocker and neprilysin inhibitor combined. prevents breakdown of ANP and BNP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When would ARNI be used?

A
  • NYHA class II-IV symptoms
  • In patients with EF 35% or less.
  • those already taking ACE/ARB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the action of sacubitral?

A

inhibits neprilysin. that prevents the breakdown of ANP and BNP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What 4 benefits do ANP and BNP provide in heart failure?

A

vasodilation, diuretics, natriuretics, and inhibit RAAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a large benefit and a negative in ARNI?

A

significantly decrease hospitalisation and mortality rates more than ACE and ARB

in high doses may cause hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a MRA?

A

mineralcorticosteroid receptor antagonist. diuretic.
block receptors that bind aldosterone, therefore causing Na+ loss and sparing K+, in distal tubule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is MRA used and what is its benefit?

A

in patients with symptoms despite other treatment - ACE/ARB/ARNI and B blockers

reduced hospitalisation and mortality significantly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 2 MRA’s?

A

spironolactone and Eplerenone

17
Q

What beta blockers do we use and on who/not?

A
  • carvedilol and bisoprolol.
  • use only on stable patients. can cause deterioration in patients with fluid overload
18
Q

Whats the positive of beta blockers?

A

decrease mortality by 30% in mild, moderate and severe HF.

19
Q

What is the mechanism and use of ivabridine?

A
  • not neurohormonal. blocks Na+ receptor in SA node to slow down HR.
  • use in patients with sinus rhythm only
  • dont use in patients with HR <70bpm or atrial fibrillarion
  • significantly reduce hospitalisation and mortality
20
Q

What is the use of positive inotropes?

A
  • digoxin we use only. reduces hospitalisation but not mortality.
  • toxicity isn’t uncommon. nausea and confusion (in elderly)
21
Q

How many drugs may a patient expect to be on following chronic heart failure?

A

many. combination theraoy shows greatest reduction in mortality and hospitalisation

22
Q

What is the therapeuric regime?

A
  • ACE. if resistant, ARB. if resistant, ARNI.
  • B Blockers and ivabradine
  • MRA
  • MAYBE digoxin and warfarin
23
Q

How do we monitor the benefit of treatment?

A
  • symptoms,
  • clinical relief
  • weight for oedema and water retention
24
Q

Which drug shouldnt be given with ACE inhibitors?

A
  • naproxen - NSAID. Reduces blood pressure lowering effect of ACE
  • can cause acute kidney injury
25
Q

What is a common side effect of ACE ? what do you give instead if they have this?

A

cough. give ARB instead - Candesartan